Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And what happened to the promised stocks of ZenaPay....??????????????
With the recent dismissals by some of the creditors it means that the Bert line is back into IMNPQ assets !!! A big boost for IMNPQ !
What is he doing in a power chair..? Is that a recent picture..?
Pathetic... I think we lost the pandemic momo.... !!
And here as well... !!
Which brokerage house are you using...?
The law does not take effect until September 28, 2021... plenty of time left.. !
I know that so does everybody else so.... what's the point?
And one more thing, I think that throwing this company into Chapter 11 after some key assets were "removed" ( others call it spin off ) was a clerical error to say it softly.. but, that's another chapter yet to be addressed. Assets were removed but still attached by a strong legal string.
I am pretty sure the Trustee hasn't gotten there yet and won't unless he gets somebody that knows about B/K proceedings. Worry not, somebody will point it out to him or whoever is there when he's no longer there. BTW, the Trustee's personal expertise on legal matters lists a few things but nothing about B/K... !!
We're in the same boat and can't guarantee that it won't sink but I can tell you that there are a couple of possibilities working at this time that could save it... whether they prevail or not I don't know but surely hope so, there are only two things that you can considered "guaranteed" in life, death and taxes.
Major stockholders (5 million shares and over) are still there, most if not all of them, didn't dump their shares on the last two weeks of fierce trading when it went up to 0.18 simply because... they didn't, not a those prices. The public float was at 36-40 million shares last I checked it. There are 181 million O/S.
Buying shares today is very difficult because the restrictions that major brokerage houses have placed however, you can sell all you want or better said, you can place your sell orders without restrictions. So, for me that I am promoting or inducing people to buy shares is idiotic and baseless...
Been in the stock for a while, long before all the recent developments and all I can tell you now, the show is not over yet, stay tuned.... !!
Just wait and see.... mon ami... !!!
The Trustee seems to have very little clue of all the assets IMNPQ may have and when time comes they will be pointed out to him, never mind maybe one or a couple of hidden players working here that may turn the table around, of course, things may not come out as you wish that all long time holders lose everything here but, au contraire mon ami, things will work out the other way around.... just 2 or 3 months..... end of the story !
No where to go... !! And, as the pandemic (sort of) fades, so will most of their products, IMO.
They can... probably at a much higher prices but I guess some of them are waiting for their dream... which may very well turn into a nightmare... soon... ! Some of them are touring in Frankfurt offering ridiculous prices for 6 million shares and other at 36 million shares but, they are way off the game since Frankfurt is trading at a much higher price than in the US...
The ultimate dream for the short sellers...!! LOL if anyone really want to help the uncovered short sellers here should advise them to cover while at these levels... prompt.. !!
And don't forget the KBG and the CIA... oh, almost forgot, the Germany's Secret Service because the stock is trading at Frankfurt SE with a last price of 0.02+ USD... !!
Because of the Trustee's inexperience and negligence besides, he needs the B/K proceedings to be endless as long as he can still milking the fat cow along with his attorneys... !! IMO
There was no reason at all for the Trustee to contact the SEC with "inaccuracies" in the latest filings first, because he knew from the previous PR's and second, never checking to be assured that the filings were fake or inaccurate, just because "someone(s)" might have told him.
Just like a jet passing over your head and then claiming you didn't hear anything... !
BTW, Adeel keeps working on this deal without making noise until... something of value may be said.
Immune Pharmaceuticals Announces Corporate Restructuring 04/27/2017
In line with this prioritization, the Company’s Board of Directors (the “Board”) has authorized Dr. Daniel Teper to lead the Company’s oncology business within the Company’s Cytovia, Inc. subsidiary and to pursue a possible spin-off of Cytovia into a separate, stand-alone company independent from Immune. Cytovia will focus on the development and commercialization of novel immuno-oncology and hematology therapeutics, led by Ceplene, an immunotherapy treatment in late stage development in combination with low dose interleukin 2 (IL-2) for the remission maintenance of patients with Acute Myeloid Leukemia; Azixa and crolibulin, two phase 2 drug candidates with synergistic potential with immuno-oncology drugs; and a bispecific antibody platform to be supported by collaborative partnerships. Under the leadership of Dr. Teper, Cytovia will aim to grow into a global specialty biopharmaceutical company through these product candidates and the acquisition of additional late stage or commercial stage oncology products. Cytovia intends to raise sufficient capital to support R&D investment through product licensing and partnership transactions, government grants and issuance of debt and equity.
A potential spin-off of Cytovia into a stand-alone company pursuing an independent path from Immune would provide several advantages:
Allows current Immune investors to benefit from two distinct investment opportunities through proportional receipt of shares in Cytovia;
Enables Cytovia to target new investors attracted to its specific oncology business profile and pursue distinct capital structures and capital allocation strategies; and
Aligns Cytovia’s resources with its stated goals and tailors its business strategy to best address opportunities within its target market of oncology
The proposed restructuring strategy recognizes that our two operating divisions have evolved into distinct business and investment opportunities. The potential Cytovia spin-off will establish each division as a separate company with a focused strategy and will enable each company to enhance its business focus, better align its resources to achieve strategic priorities, target investors attracted to its unique business profile, and ultimately unlock significant value for both companies”, said Dr Daniel Teper.
In connection with this restructuring, the Company’s Board has accepted the resignation of Dr. Daniel Teper as CEO of Immune, effective immediately, so that he may focus his efforts exclusively on leading Cytovia. The terms of the resignation are specified in a Separation Agreement entered into by and between Dr. Teper and the Company on April 21, 2017. Dr. Teper will remain a member of the Company’s Board and will focus his efforts, in conjunction with the Board, on developing and beginning execution of the plan to spin off Cytovia into an independent, stand-alone oncology business.
The Company’s Board has appointed Elliot Maza, JD, CPA as interim CEO, effective immediately, to serve until a new CEO of Immune is identified. Mr. Maza has served as a member of the Board and Chairman of the Audit Committee of the Board since January 14, 2015. Mr. Maza served as a consultant to the Company from November 2014 to January 2015. In connection with his appointment to the position of interim CEO, Mr. Maza will resign from the Audit Committee of the Board but will continue to serve as a director.
Dr. Monica E. Luchi, Executive Vice President Global Drug Development and Chief Medical Officer, will assume the title of President, Immune Pharmaceuticals Inflammatory Disease and Dermatology Division. Under the leadership of Mr. Maza and Dr. Luchi, Immune will focus its business on immuno-inflammation in general, and immuno-dermatology in particular, by developing its core asset, bertilimumab, a first in class human monoclonal antibody in phase 2 development in bullous pemphigoid and ulcerative colitis and with application for severe atopic dermatitis. Immune intends to continue to focus on the development of topical nano-cyclosporine for the treatment of atopic dermatitis and moderate psoriasis.
This is the Cytovia I am referring to
www.cytoviatx.com
He (Trustee) contradicts himself with the latest filings about the offer and the counter offer. Also I think that this process has taken so long to resolve one way or the other is the lack of experience in these proceedings.
After more than two years into this, he is now going after Wuxi for the money owed to IMNPQ from Wuxi. Not a word about IMNPQ's stake into Cytovia and/or IP's taken from IMNPQ into Cytovia. Who knows what else is there the Trustee hasn't discovered yet... !!
I think this company missed the pandemic train ride all together... !!
Try back in 30 days or so... !!
Trading IMNPQ in Frankfurt this morning - Prices in Euro = $ 1.22 USD
11/05/21 12:32:46
Last price 0.0165
Change to prev. day +6.45%
11/05/21 13:03:38
Bid Ask
0.015 0.0265
for 80,000 units for 35,000 units
Change to prev. day 0.001 / 6.45%
Spread absolute / relative 0.0115 / 76.67%
Trading in Frankfurt so far.... still 3 hours to close
Last trade was 0.026 Euros or 0.0312 USD
Day's high was over 0.06 USD
Price information IMMUNE PHARMAC. DL-,0001
Turnover in euro 12,122
Turnover in units 309,400
Price fixings 9
Closing price prev trading day 0.0185
Day range 0.018 / 0.0535
52 week range 0.002 / 0.30
Trading hours 08:00-20:00
Sorry, correction, it closed at 0.022 USD, still good !
Frankfurt's closing price for IMNPQ was 0.27 Euros or 0.032 USD... !
Going up in Frankfurt now... Ask well over 0.04 USD - Below quotes in Euros
06/05/21 15:26:53
Last price 0.027
Change to prev. day -22.86%
06/05/21 16:15:43
Bid Ask
0.0135 0.0345
for 238,462 units for 91,177 units
Change to prev. day -0.008 / -22.86%
Spread absolute / relative 0.021 / 155.56%
Frankfurt Stock Exchange - Trading on IMNPQ = FZRQ.F
https://www.boerse-frankfurt.de/equity/immune-pharmac-dl-0001
Thank you... that was funny.... !!
Not really... watch, like many others do, Pete's nose, once it starts growing again, the stock will move up again... !!
This is not a scam. The 8-k's were real and wasnot a pump and ump. The company in Delaware is real and IMPNQ is not been liquidated... !! did I miss anything..???
This is a scam. The 8K’s were fake, fabricated to set up a pump and dump. The company in Delaware the stock is legally tied to is in Chapter 7 bankruptcy, being liquidated, and shut down for good.
What about those who failed to report by the 15th last...??
Wait til those "non-existent" shorts need to cover and can't find shares...!
No, no... those fillings were fake, this is a scam, there are no shorts and the IMNPQ won't come out of this alive... and the more I say it don't know why, my nose keeps growing up...!!! LOL
The company has been in B/K well over two years now yet, it kept trading, nothing was of been "scam" and "fake" until Monday the 19th and have been repeated over and over again for the past two weeks, even thou the SEC trading suspension did not mention anything about scam or fake... how come we weren't warned before the 19th, the increased daily volume kept going for a month or so, maybe more... !!!
It's been said that bravery is hard to come and fear easy to spread and it applies to IMNPQ as well as to the rest of them... ! IMNPQ will do well, whether in the grey or any other color... lots of potential an assets never mind Cytovia... !!
And also, let's count those "boiler rooms" that shorted the stock and didn't report their position before the 15th of April and if so, maybe because "too much work" and missed the dateline... !
Anyway, on Monday we will all know... ! If nothing happens before that...
Buying Puts at these levels...? Risky... !!
Suspect we may see some more 8-Ks filed soon... IMO